Active surveillance for prostate cancer with selective delayed definitive therapy

Area of Science:

• Urology
• Oncology
• Decision Science

Background:

• Localized prostate cancer presents diverse management options.
• Risk stratification and patient preferences are crucial for treatment decisions.
• Early detection leads to earlier diagnosis, necessitating nuanced management strategies.

Purpose of the Study:

• To review the current understanding of active surveillance for localized prostate cancer.
• To explore the role of selective delayed definitive therapy.
• To inform patients and physicians on risk-adjusted treatment choices.

Main Methods:

• Literature review of active surveillance protocols and outcomes.
• Analysis of patient utility in decision-making for prostate cancer.
• Synthesis of data on risk stratification and treatment response.

Main Results:

• Active surveillance is a viable option for select prostate cancer patients.
• Delayed definitive therapy is indicated upon signs of cancer progression.
• Patient utilities can quantify risks and benefits of different therapeutic paths.

Conclusions:

• Active surveillance with selective delayed therapy offers a personalized approach to localized prostate cancer management.
• This strategy empowers patients to actively participate in their care decisions.
• Further research should refine criteria for active surveillance and optimize treatment timing.